Connect with us

Technology

Revolune and Concept Life Sciences Partner to Help Customers Transition Multiplex IF Assays to Flexible New Workflows

Published

on

OBERKOCHEN, Germany, Oct. 27, 2026 /PRNewswire/ — Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and scale multiplex immunofluorescence assays using Revolune’s flexible staining technology, which now supports 4- to 7-plex assays. 

The collaboration addresses a growing market need as customers evaluate alternatives to existing workflows and reconsider how best to support tissue biomarker research. With Revolune now offering 4- to 7-plex assay capabilities, Concept Life Sciences can help customers transfer established assays onto the Revolune platform, preserve valuable panel know-how, and move more easily from existing workflows to flexible, ready-to-use multiplex formats. 

“Many customers are not starting from a blank page — they already have assays, panels, and tissue biomarker strategies they need to preserve while moving toward more flexible workflows,” said Adrian Arechiga, CCO of Revolune. “Concept Life Sciences brings the translational biology, biomarker, and assay development expertise needed to help customers make that transition practically and confidently.” 

Concept Life Sciences is a leading contract research organization serving the global life sciences industry, with capabilities across discovery, development, analytical services, translational biology, biomarker discovery, spatial biology, and end-to-end chemistry. By combining these capabilities with Revolune’s adaptable multiplex immunofluorescence technology, the companies aim to help customers generate decision-ready tissue biomarker insights while reducing the operational burden of assay transfer and implementation. 

The partnership is designed for research teams that want to retain the scientific value of existing workflows while gaining access to a more flexible platform for multiplex staining. Customers can work with Concept Life Sciences to evaluate assay transfer feasibility, optimize panel design, run tissue staining workflows, and connect resulting biomarker data to broader discovery and development programs. 

“We are excited to work with Revolune to support customers who are rethinking how they approach multiplex tissue analysis,” said Adam Davenport, CSO at Concept Life Sciences. “Together, we can help teams transfer existing assays, explore new panels, and apply multiplex immunofluorescence in ways that support meaningful translational decisions.” 

The Concept Life Sciences partnership forms part of Revolune’s broader strategy to build an ecosystem of partners that support adoption across different customer needs — from specialist service execution to assay migration, translational biology, and integrated R&D support.

Meet Revolune and Concept Life Sciences at SITC 2026

Revolune and Concept Life Sciences will both be attending the Society for Immunotherapy of Cancer (SITC) Annual Meeting, November 4–8, 2026, in Phoenix, Arizona. 

Meet both teams at SITC at Sundown, a relaxed evening of complimentary drinks, dinner and conversation hosted by Concept Life Sciences on November 6, 6.30-8.30 pm. More information: https://www.conceptlifesciences.com/campaigns/sitc-2026.

About Revolune

Revolune is a life science company dedicated to making multiplex immunofluorescence as accessible and practical as routine tissue analysis. Its reagent technologies help laboratories move rapidly from existing primary antibodies to ready-to-use multiplex kits, simplifying spatial biology workflows and enabling researchers to focus on biological questions rather than assay management. 

About Concept Life Sciences

Concept Life Sciences is a leading contract research organisation (CRO) serving the global life sciences industry. For over 25 years, the company, and its heritage companies, have provided consultative and collaborative drug discovery and development services. Our approach, supported by passionate scientists and world-leading capabilities, enables clients to overcome complex scientific challenges and improves program success rates. The company has successfully helped 29 candidates advance to the clinic.

The company offers sophisticated translational biology services coupled with exceptional end-to-end chemistry capabilities to support drug discovery and development across a range of established and emerging modalities, with the ability to seamlessly integrate capabilities and provide bespoke solutions to address client needs.

Collectively, the company’s high-quality services and commitment to customer service across the drug development pathway enhances efficiency in drug discovery, helping clients advance their drugs to clinic in as little as 32 months, well ahead of the industry average of 60 months.

View original content to download multimedia:https://www.prnewswire.com/news-releases/revolune-and-concept-life-sciences-partner-to-help-customers-transition-multiplex-if-assays-to-flexible-new-workflows-302919466.html

SOURCE Revolune

Continue Reading

Technology

Elementix and Lightning Docs Announce Reporting Partnership to Deliver Industry-Comprehensive Data on Business-Purpose Lending

Published

on

By

Each company’s monthly report will draw on shared recorded transaction data and loan-level document data, giving lenders, brokers, and investors a more complete view of current bridge, fix-and-flip, construction, and DSCR lending.

IRVINE, Calif., Oct. 27, 2026 /PRNewswire/ — Elementix, a leading provider of aggregated data on business-purpose lending, and Lightning Docs, the premier loan document automation platform for private lenders, Non-QM lenders, credit unions, and law firms, today announced a data-sharing partnership to strengthen reporting on the business-purpose lending market.

The partnership brings together two complementary datasets. Elementix aggregates recorded real estate transactions nationwide, including mortgages, deeds, satisfactions, assignments, and preforeclosure filings, providing a comprehensive picture of lender activity, loan volume, and market share. Lightning Docs captures loan-level terms at the point of document generation, including interest rates, loan amounts, and loan structures, from a document automation platform used by 60% of the nation’s top 50 private lenders. Combined, the two sources produce a level of coverage and detail that has been unprecedented in the private lending space.

“Private lending has long been an opaque industry, with limited data on interest rates, loan amounts, geographic trends, and other metrics that are vital to running a profitable operation,” said Nema Daghbandan, CEO of Lightning Docs. “Lightning Docs set the standard for monthly private lending market reporting, and this partnership raises it. By pairing our loan-level data with Elementix’s transaction data, we are delivering reporting with the scale, precision, and depth the market has been missing, and providing lenders, brokers, and investors a clearer view of the industry than they have ever had before.”

Each report, delivered at a regular monthly cadence, will cover bridge, fix-and-flip, ground-up construction, and DSCR loans, with aggregated data on interest rates, loan amounts, loan volume, lender activity, geographic trends at the state and regional level. All data will be aggregated and anonymized, with no borrower- or lender-specific loan terms disclosed.

“Managing risk in private lending starts with understanding the borrower and the broader market, yet lenders often have to make decisions with incomplete information. Elementix was built to help lenders understand that risk through public record data, and partnering with Lightning Docs adds the loan-level detail that completes the picture. Together, we’re helping lenders better understand market conditions and bring that context into how they assess and manage risk,” said Cameron Kelliher, founder and CEO of Elementix.

The first joint report is scheduled for release in November 2026. Reports will be published on the Lightning Docs and Elementix websites and distributed to subscribers of both companies.

About Elementix
Elementix is the borrower intelligence platform for private lenders. It helps lenders identify active investors, verify experience for better credit decisions, and reach decision-makers with leading contact data accuracy. For more information, visit www.elementix.com.

About Lightning Docs
Initially developed by nationally recognized private lending attorneys, Lightning Docs is the industry’s leading automated loan document software for lenders who make business-purpose loans. The platform instantly produces attorney-grade, compliant loan documents across all 50 states. It covers every business-purpose loan type, including short-term bridge and fix-and-flip loans, 30-year DSCR rental loans, ground-up construction, and complex modifications. Lightning Docs is the official loan document software of the American Association of Private Lenders®. More than 60% of the nation’s top 50 private lenders use it, along with many of the country’s largest Non-QM lenders. Since 2018, lenders have originated more than $100 billion using Lightning Docs. For more information, visit www.lightningdocs.ai.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elementix-and-lightning-docs-announce-reporting-partnership-to-deliver-industry-comprehensive-data-on-business-purpose-lending-302921069.html

SOURCE Lightning Docs LLC

Continue Reading

Technology

Therap Services Enhances Therap Connect with Personalized Sleep Insights for Human Services Providers

Published

on

By

TORRINGTON, Conn., Oct. 27, 2026 /PRNewswire/ — Therap Services, the national leader in HIPAA-compliant electronic documentation solutions for Intellectual and Developmental Disabilities (IDD), Home and Community-Based Services (HCBS), and Long-Term Services and Supports (LTSS) industries, has introduced advanced Personalized Sleep Insights to its Therap Connect platform. This enhancement integrates ambient room monitoring with sleep tracking data to help care teams understand and optimize environmental factors affecting the sleep quality of individuals.

Understanding Environmental Factors for Better Rest

Tracking overnight sleep patterns is vital for maintaining physical health, emotional well-being, and individual safety. The updated Therap Connect module introduces a ‘Personalized Sleep Insights’ feature that evaluates three months of historical data from Withings sleep monitors and Watchdog room sensors. By evaluating sleep start times alongside ambient room temperature and humidity, the system highlights optimal environmental conditions to support healthier sleep habits and proactive care planning.

Streamlined Platform Workflows and Daily Tracking

Designed for ease of use, this update helps teams manage daily monitoring more efficiently. Staff can quickly review overnight alerts directly on dashboard views, manage notification settings in one place, and conveniently copy form details with a single click. These practical updates save time on routine administrative tasks, allowing care managers and staff to focus on monitoring health parameters.

Frequently Asked Questions (FAQs)

Does Therap Connect offer sleep tracking capabilities? 

Yes. Therap Services provides integrated sleep and health tracking through Therap Connect, combining continuous sensor data with daily documentation tools.

How do Personalized Sleep Insights in Therap Services help human services providers?

It analyzes sleep schedules, room temperature, and humidity data to identify optimal sleep environments, helping care teams make data-informed adjustments to support health outcomes.

Does Therap Connect require extra software for sleep tracking? 

No. Therap Connect operates through its own dedicated, secure web-based portal, allowing teams to access environmental and sleep tracking insights natively without installing third-party software.

For more information about Therap Connect, please visit: https://www.therapconnect.net/

About Therap Services

Therap Services provides HIPAA-compliant software for documentation, communication, reporting, EVV, and billing.

Learn more: https://www.therapservices.net/

View original content:https://www.prnewswire.com/news-releases/therap-services-enhances-therap-connect-with-personalized-sleep-insights-for-human-services-providers-302921017.html

SOURCE Therap Services

Continue Reading

Technology

Meet Providi: One Company Behind Cerbo and OptiMantra

Published

on

By

The new name reflects a long-term commitment to the cash-pay personalized care market, where Cerbo and OptiMantra keep their brands and together serve nearly 7,000 clinics.

ATLANTA, Oct. 27, 2026 /PRNewswire/ — Providi launched today as the corporate brand of the company behind Cerbo and OptiMantra, two long-standing products in the cash-pay personalized care market. The companies combined in 2025, backed by a growth investment from Mainsail Partners. Cerbo and OptiMantra will continue as product brands within Providi.

Together, the two providers of electronic health record (EHR) and practice management products support nearly 7,000 clinics. These include functional, integrative, longevity, wellness, direct primary care, concierge, med spa and behavioral health practices. Both have served the market since 2011.

The name Providi combines “provi,” for the provider at the center of every practice, with “vidi,” Latin for “I saw.” It stands for a company that starts with the provider and can see where personalized care is going.

Providi’s mission is to empower personalized care providers to deliver better patient outcomes and create thriving practices. That mission is already shaping the product roadmap. With the Cerbo and OptiMantra teams building together, new capabilities reach providers faster, and AI Scribe is the first example. Available now, Cerbo AI Scribe captures visit notes automatically, so providers spend less time charting between visits or after hours. OptiMantra AI Scribe, built on lessons from the Cerbo launch, is coming to OptiMantra providers soon.

“Personalized care providers built this market one practice at a time, each one designed around the time, attention and care they believe every patient deserves,” said Jeff Hindman, CEO of Providi. “Cerbo and OptiMantra have each earned the trust of thousands of practices, and Providi exists to amplify that work. Coming together as one company accelerates the innovation we can bring to market and enables us to invest more in both products. Our focus remains giving the providers already running our products and the new providers entering the market the technology they need to succeed.”

Providers can expect to log in to the same Cerbo and OptiMantra products, reach out to the same reps and receive support, onboarding and product updates the same way they do today. They will start to see the Providi name at combined events and in company communications, and they’ll feel it in their products: two teams sharing what they learn, active investment in both products and new capabilities reaching their practices sooner.

About Providi

Providi is the company behind Cerbo and OptiMantra, two electronic health record (EHR) and practice management products serving the cash-pay personalized care market. Together, Cerbo and OptiMantra support nearly 7,000 clinics in functional, integrative, longevity, wellness, direct primary care, concierge, med spa and behavioral health. Providi is committed to meeting the specialty workflow needs of these practices and continues to invest in both products to help providers achieve better patient outcomes, grow their practices and operate more efficiently. For more information, visit providico.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/meet-providi-one-company-behind-cerbo-and-optimantra-302921038.html

SOURCE Providi

Continue Reading

Trending